Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Liubov I. Popova"'
Autor:
Fedor A. Asadi Mobarkhan, Victor A. Manuylov, Anastasia A. Karlsen, Vera S. Kichatova, Ilya A. Potemkin, Maria A. Lopatukhina, Olga V. Isaeva, Eugeniy V. Mullin, Elena P. Mazunina, Evgeniia N. Bykonia, Denis A. Kleymenov, Liubov I. Popova, Vladimir A. Gushchin, Artem P. Tkachuk, Anna A. Saryglar, Irina E. Kravchenko, Snezhana S. Sleptsova, Victor V. Romanenko, Anna V. Kuznetsova, Sergey A. Solonin, Tatyana A. Semenenko, Mikhail I. Mikhailov, Karen K. Kyuregyan
Publikováno v:
Vaccines, Vol 11, Iss 2, p 430 (2023)
A neonatal vaccination against the Hepatitis B virus (HBV) infection was initiated in Russia 20 years ago, with catch-up immunization for adolescents and adults under the age of 60 years launched in 2006. Here, we have assessed the humoral immunity t
Externí odkaz:
https://doaj.org/article/5128735104cd43b5a97f9ceb52760a5c
Autor:
Mikhail I. Mikhailov, Anastasia A. Karlsen, Ilya A. Potemkin, Olga V. Isaeva, Vera S. Kichatova, Elena Yu. Malinnikova, Fedor A. Asadi Mobarkhan, Eugeniy V. Mullin, Maria A. Lopatukhina, Victor A. Manuylov, Elena P. Mazunina, Evgeniia N. Bykonia, Denis A. Kleymenov, Liubov I. Popova, Vladimir A. Gushchin, Artem P. Tkachuk, Andrey D. Polyakov, Ahmed Mohammed Eladly, Sergey A. Solonin, Ilya V. Gordeychuk, Karen K. Kyuregyan
Publikováno v:
Viruses, Vol 15, Iss 1, p 37 (2022)
The factors influencing hepatitis E virus (HEV) circulation remain largely unexplored. We investigated HEV seroprevalence in humans and the prevalence of infection in farm pigs and rabbits in different regions of the Russian Federation, as well as th
Externí odkaz:
https://doaj.org/article/908122af36d24f4b9d28e37600e7eb11
Autor:
Denis A. Kleymenov, Evgeniia N. Bykonia, Liubov I. Popova, Elena P. Mazunina, Vladimir A. Gushchin, Liudmila V. Kolobukhina, Olga A. Burgasova, Irina S. Kruzhkova, Nadezhda A. Kuznetsova, Elena V. Shidlovskaya, Elizaveta V. Divisenko, Andrei A. Pochtovyi, Valeria V. Bacalin, Svetlana V. Smetanina, Artem P. Tkachuk, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine release can expand our understanding of the initial stages of disease devel
Externí odkaz:
https://doaj.org/article/447677bb15474989b59f770f789a736f
Autor:
Elena V. Abakushina, Liubov I. Popova, Andrey A. Zamyatnin, Jens Werner, Nikolay V. Mikhailovsky, Alexandr V. Bazhin
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1363 (2021)
In the last decade, an impressive advance was achieved in adoptive cell therapy (ACT), which has improved therapeutic potential and significant value in promising cancer treatment for patients. The ACT is based on the cell transfer of dendritic cells
Externí odkaz:
https://doaj.org/article/81a28abc7b514f69917fa462aecbcb95
Autor:
Artem P. Tkachuk, Evgeniia N. Bykonia, Liubov I. Popova, Denis A. Kleymenov, Maria A. Semashko, Vladimir P. Chulanov, Sergey B. Fitilev, Semyon L. Maksimov, Elena A. Smolyarchuk, Victor A. Manuylov, Daria V. Vasina, Vladimir A. Gushchin, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 8, Iss 4, p 652 (2020)
GamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a, ESAT6, CFP10, and a dextran-binding domain (DBD). Phase II of a double-blind, randomized, multicenter, placebo-controlled study in parallel groups in healthy adu
Externí odkaz:
https://doaj.org/article/6df5a455213341a6a73b051422a1a694
Autor:
Mikhail I. Mikhailov, Anastasia A. Karlsen, Ilya A. Potemkin, Olga V. Isaeva, Vera S. Kichatova, Elena Yu. Malinnikova, Fedor A. Asadi Mobarkhan, Eugeniy V. Mullin, Maria A. Lopatukhina, Victor Manuylov, Elena P. Mazunina, Evgeniia N. Bykonia, Denis A. Kleymenov, Liubov I. Popova, Vladimir A. Gushchin, Artem P. Tkachuk, Andrey D. Polyakov, Ahmed M. El-Adly, Sergey A. Solonin, Ilya Gordeychuk, Karen Kyuregyan
The factors influencing hepatitis E virus (HEV) circulation remain largely unexplored. We investigated HEV seroprevalence in humans and the prevalence of infection in farm pigs and rabbits in different regions of the Russian Federation, as well as th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57ed2d00e69967150a36843d6f473e17
https://doi.org/10.20944/preprints202211.0286.v1
https://doi.org/10.20944/preprints202211.0286.v1
Autor:
Alexander V. Grishin, Nikita V. Shestak, Natalia V. Lavrova, Alexander M. Lyashchuk, Liubov I. Popova, Natalia V. Strukova, Maria S. Generalova, Anna V. Ryazanova, Nikita B. Polyakov, Zoya M. Galushkina, Lyubov A. Soboleva, Irina S. Boksha, Anna S. Karyagina, Vladimir G. Lunin
Publikováno v:
Molecules, Vol 24, Iss 16, p 2892 (2019)
Antibacterial lysins are promising proteins that are active against both antibiotic-susceptible and antibiotic-resistant bacterial strains. However, a major limitation of antibacterial lysins is their fast elimination from systemic circulation. PEGyl
Externí odkaz:
https://doaj.org/article/4465414831854562a6f2736da385758d
Autor:
Evgeniia N. Bykonia, Denis A. Kleymenov, Elena P. Mazunina, Liubov I. Popova, Victor A. Manuylov, Vladimir A. Gushchin, Artem P. Tkachuk, Alexander L. Gintsburg
Publikováno v:
Journal of Immunological Methods. 512:113408
Serosurveillance and seroprevalence studies should be carried out to monitor vaccine-preventable diseases. Multiplex immunoassay (MIA) systems are useful tools for this purpose, allowing the simultaneous quantitative detection of antibodies in one sm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82bea5f65bf4b13a319c3f6d500d15ac
https://doi.org/10.1016/j.jim.2022.113408
https://doi.org/10.1016/j.jim.2022.113408
Autor:
D. A. Kleymenov, Anna V. Kovyrshina, Nadezhda L. Lubenets, Natalia A. Nikitenko, Sergei V. Borisevich, Alexander S. Semikhin, Elizaveta A. Tokarskaya, Daria M. Grousova, Andrey Pochtovyi, M M Shmarov, Dmitry V. Shcheblyakov, Olga Popova, Shchetinin Am, Tatiana A Ozharovskaya, Andrey Komissarov, Evgeniia N. Bykonia, Alina S. Dzharullaeva, Dmitry Lioznov, Alexander L. Gintsburg, Artem P. Tkachuk, A. I. Tukhvatulin, Denis Y. Logunov, Nadezhda P. Kuznetsova, Liubov I. Popova, Olga V. Zubkova, Inna V. Dolzhikova, Lyudmila Vasilchenko, Elena V. Shidlovskaya, Alina S. Erokhova, E. P. Mazunina, Boris S. Naroditsky, Alexander Tsybin, Elizaveta V. Divisenko, Vladimir A. Gushchin, Daria Danilenko, Fatima M. Izhaeva
ObjectivesVaccination remains the most effective response to the COVID-19 pandemic. Most vaccines use two-dose regimens. In turn, single-dose vaccines also have high potential, since, on the one hand, they simplify the vaccination program, make it mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f145807fe93e4a55dadded1a8a6b758
https://doi.org/10.1101/2021.10.08.21264715
https://doi.org/10.1101/2021.10.08.21264715
Autor:
Andrey A. Zamyatnin, Jens Werner, Nikolay V. Mikhailovsky, Liubov I. Popova, Elena V. Abakushina, Alexandr V. Bazhin
Publikováno v:
Vaccines, Vol 9, Iss 1363, p 1363 (2021)
Vaccines
Vaccines
In the last decade, an impressive advance was achieved in adoptive cell therapy (ACT), which has improved therapeutic potential and significant value in promising cancer treatment for patients. The ACT is based on the cell transfer of dendritic cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14ab6a2cc8fc27b0b3b66d11d2b68c8
https://doi.org/10.3390/vaccines9111363
https://doi.org/10.3390/vaccines9111363